Provided by Tiger Fintech (Singapore) Pte. Ltd.

CANSINOBIO

44.160
+0.1800.41%
Volume:670.71K
Turnover:29.42M
Market Cap:10.91B
PE:-26.36
High:44.580
Open:43.960
Low:43.200
Close:43.980
52wk High:56.550
52wk Low:25.250
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:1.03
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.675
ROE:-2.84%
ROA:-1.87%
PB:2.02
PE(LYR):-26.36
PS:10.25

Loading ...

CanSino Biologics Begins Phase 1 Trial of Tuberculosis Booster Vaccine in Indonesia

MT Newswires Live
·
Yesterday

CanSino Biologics (6185) Announces Phase I Clinical Trial Launch and First Patient Enrollment for Inhaled TB Booster in Indonesia

Bulletin Express
·
Yesterday

CanSino Biologics Inc. (6185) Announces 2025 Second Extraordinary General Meeting Notice

Bulletin Express
·
Nov 11

CanSino Biologics Inc. (6185) Issues Proxy Form for 2025 Second Extraordinary General Meeting

Bulletin Express
·
Nov 11

CanSino Biologics (6185) Announces Board of Supervisors Cancellation, Governance Updates, and Director Nominations

Bulletin Express
·
Nov 11

CanSino Biologics to Use Reserves to Offset Accumulated 1.45 Billion Yuan Losses; Shares Gain 3%

MT Newswires Live
·
Nov 10

CANSINOBIO (06185) Proposes Using Capital Reserve to Offset Losses

Stock News
·
Nov 07

CanSino Biologics Inc. (6185) Announces Plan to Use Reserves to Offset Accumulated Losses

Bulletin Express
·
Nov 07

UBS Slightly Lowers CANSINOBIO (06185) Target Price to HK$64, Maintains "Buy" Rating

Stock News
·
Nov 03

Stock Track | CANSINOBIO Soars 5% as Q3 Net Profit Skyrockets 842%, Driven by Strong MenHibrix Sales

Stock Track
·
Oct 31

Stock Track | CANSINOBIO Soars 5.01% as Q3 Profit Surges 842% on Strong MenHibrix Sales

Stock Track
·
Oct 31

HK Stock Movement | CANSINOBIO (06185) Rises Over 4% Again, Q3 Net Profit Surges 8-Fold YoY with Core Product MenHibrix Showing Strong Growth

Stock News
·
Oct 31

CanSino Biologics Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Simply Wall St.
·
Oct 30

CanSino Biologics' Profit Soars 842% in Q3; Shares Gain 4%

MT Newswires Live
·
Oct 28

CanSino Biologics Inc. Announces Updated Remuneration and Assessment Committee Terms of Reference

Bulletin Express
·
Oct 27

CanSino Biologics Inc. Publishes Nomination Committee Terms of Reference

Bulletin Express
·
Oct 27

CanSino Biologics Inc. Announces Updated Audit Committee Terms of Reference

Bulletin Express
·
Oct 27

CANSINOBIO (06185) Reports Q3 Earnings with Net Profit of RMB14.44 Million

Stock News
·
Oct 27

CanSino Biologics Inc. (6185) Announces Proposed Cancellation of Board of Supervisors, Governance Amendments, Director Resignations, and Nominations

Bulletin Express
·
Oct 27

CANSINOBIO (06185): Zuo Min and Ji Xuefeng Nominated as Independent Non-Executive Director Candidates

Stock News
·
Oct 27